Impact of timing of atrial fibrillation, CHA
atrial fibrillation
malignancy
risk factors
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
03
08
2020
revised:
23
10
2020
accepted:
09
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
23
7
2021
Statut:
ppublish
Résumé
To investigate timing and age distribution of atrial fibrillation (AF) in selected oncology patients, and the impact of AF timing, CHA This is a retrospective cohort study of oncology patients referred to the cardio-oncology service from 2011 to 2018 for echocardiographic cardiosurveillance and/or pre-existing cardiovascular risk factor/disease management. Rates of first AF diagnosis was assessed using a parametric multiphase hazard model (predictive modelling) and non-parametrically by Kaplan-Meier with transformations tested using a bootstrap methodology. Among 6754 patients identified, 174 patients had their first AF diagnosis This study reports a nuanced/complex relationship between AF and cancer. First diagnosis of AF in patients with cancer was more common at/early after cancer diagnosis, especially in older patients and those exposed to cardiotoxic treatment. Pre-existing AF or a diagnosis of AF within 3 years after cancer diagnosis carried a negative prognosis. CHA
Identifiants
pubmed: 33243931
pii: openhrt-2020-001412
doi: 10.1136/openhrt-2020-001412
pmc: PMC7692982
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Prev Chronic Dis. 2016 Nov 17;13:E157
pubmed: 27854420
J Cardiothorac Surg. 2012 Jan 10;7:4
pubmed: 22233837
PLoS One. 2016 May 05;11(5):e0154931
pubmed: 27148877
Am J Cardiol. 2015 Apr 15;115(8):1090-4
pubmed: 25711434
Heart Rhythm. 2015 Mar;12(3):554-559
pubmed: 25460854
Am J Cardiol. 2020 Dec 15;137:118-124
pubmed: 32991858
JAMA Netw Open. 2019 Sep 4;2(9):e1911838
pubmed: 31539076
Intern Emerg Med. 2008 Sep;3(3):227-31
pubmed: 18320149
Curr Oncol Rep. 2019 Apr 4;21(5):45
pubmed: 30949848
Circulation. 2004 Aug 31;110(9):1042-6
pubmed: 15313941
Eur Heart J. 2012 Jun;33(12):1500-10
pubmed: 22246443
Circulation. 2017 Oct 24;136(17):1588-1597
pubmed: 29038167
J Clin Epidemiol. 2016 Nov;79:167-168
pubmed: 27373196
J Cardiovasc Electrophysiol. 2011 Aug;22(8):839-45
pubmed: 21410581
J Epidemiol. 2016;26(4):191-8
pubmed: 26639750
Int J Cardiol. 2016 Sep 15;219:186-94
pubmed: 27327505
Clin Epidemiol. 2017 Jan 24;9:53-62
pubmed: 28182159
Circulation. 2013 Sep 3;128(10):1085-93
pubmed: 23908348
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513
JACC CardioOncol. 2020 Aug 28;2(3):400-410
pubmed: 34396248
Front Pharmacol. 2018 Oct 16;9:1058
pubmed: 30386232
Circulation. 2006 Jul 11;114(2):119-25
pubmed: 16818816
PLoS One. 2018 Oct 5;13(10):e0205454
pubmed: 30289944
Circulation. 2018 Feb 20;137(8):e30-e66
pubmed: 29437116
BMC Cancer. 2019 Nov 14;19(1):1105
pubmed: 31726997
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
J Am Coll Cardiol. 2014 Mar 18;63(10):945-53
pubmed: 24361314
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719860676
pubmed: 31319783
Circulation. 2018 Mar 6;137(10):1027-1038
pubmed: 29129827
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46
pubmed: 26112199